⚕️ For informational purposes only. Not medical advice. Learn more

🦠
Infectious Disease 13 min read May 12, 2026

Hantavirus 2026: Symptoms, Blood Tests, Diagnosis and Everything You Need to Know

Hantavirus is back in the headlines. This rare but potentially fatal rodent-borne virus causes two serious diseases — Hantavirus Pulmonary Syndrome (HPS) in the Americas and Hemorrhagic Fever with Renal Syndrome (HFRS) in Europe and Asia. This comprehensive guide explains exactly what Hantavirus is, how it is transmitted, what symptoms to watch for, which blood tests diagnose it, how to read those results, and when to seek immediate medical care.

N

Dr. Naeem Mahmood Ashraf

PhD, Biochemistry & Biotechnology

Hantavirus is trending — and for good reason. This rare but serious rodent-borne virus has resurfaced in global health discussions, with cases being reported and health authorities in the United States, Europe, and Asia issuing updated guidance. Unlike many viral illnesses, Hantavirus does not spread from person to person — but it is potentially fatal, and its early symptoms are deceptively ordinary: fever, muscle aches, fatigue. The danger is that by the time the disease reveals its true severity — flooding the lungs with fluid or shutting down the kidneys — precious hours can be lost. Understanding Hantavirus, knowing what blood tests diagnose it, and learning how to read those results could be the difference between life and death. This guide gives you everything you need to know, in plain language, backed by CDC, WHO, and NHS guidance.

What Is Hantavirus? The Essentials

Hantavirus is a family of RNA viruses belonging to the Hantaviridae family, carried and transmitted by rodents — particularly mice and rats. Infected rodents shed the virus in their urine, droppings, and saliva. Humans become infected primarily through inhalation of contaminated dust particles disturbed while cleaning, working in rural areas, or camping near rodent habitats. There are over 20 known strains of Hantavirus, each associated with a specific rodent host and geographic region. The two clinically most important syndromes are:

  • Hantavirus Pulmonary Syndrome (HPS): caused primarily by the Sin Nombre virus in the Americas. The virus fills the lungs with fluid (pulmonary oedema) — case fatality rate is 30 to 40%. The deer mouse (Peromyscus maniculatus) is the primary US reservoir
  • Hemorrhagic Fever with Renal Syndrome (HFRS): caused by Hantaan, Seoul, Puumala, and Dobrava viruses — prevalent in Europe, Asia, and worldwide. Puumala virus is the most common European strain, carried by the bank vole, and causes a milder form called Nephropathia epidemica in Scandinavia and Central Europe
  • Seoul virus: carried by the common brown rat (Rattus norvegicus) — found globally on every inhabited continent, including the UK and USA
  • Andes virus: the only known Hantavirus strain with documented person-to-person transmission — found in South America (Argentina, Chile)

Hantavirus does NOT spread through coughing, sneezing, or touching an infected person — with the exception of the Andes virus strain in South America. The primary transmission route globally is breathing in dust contaminated with infected rodent droppings, urine, or nesting materials.

Hantavirus Symptoms — Early Warning Signs You Must Not Ignore

The insidious danger of Hantavirus is that its early symptoms are non-specific — easily mistaken for flu, COVID-19, or a common viral infection. The disease progresses in clearly defined phases, and recognising the transition between them is clinically critical.

  • Incubation period: 1 to 5 weeks after exposure to infected rodent material — most commonly 2 to 4 weeks
  • Early phase (Prodromal stage, days 1–5): fever (38–40°C / 100.4–104°F), severe muscle aches (myalgia) — especially in thighs, hips, and back — headache, chills, fatigue, and sometimes nausea, vomiting, and abdominal pain
  • Late phase HPS (days 4–10): the "cardiopulmonary phase" — rapid onset of shortness of breath, dry cough, and fluid in the lungs (non-cardiogenic pulmonary oedema). This phase can deteriorate within hours and requires ICU admission
  • Late phase HFRS (days 3–7): kidney failure phase — decreased urine output (oliguria), severe back and flank pain, haemorrhage (bleeding under skin, petechiae), low blood pressure, electrolyte imbalances
  • Recovery phase: if survived, kidney function gradually returns over weeks to months

The critical transition in HPS occurs when shortness of breath develops after a few days of flu-like illness. This is the medical emergency. If you or someone near you has had rodent exposure AND develops sudden breathlessness after a fever — this is a 999 / 911 situation. Do not wait.

Who Is at Risk? Exposure Sources in the US, UK, and Europe

Hantavirus disproportionately affects people with outdoor, rural, or agricultural exposure. Understanding your personal risk is the first step in prevention.

  • United States: approximately 850 confirmed HPS cases have been reported since 1993 (CDC data). The Four Corners region (New Mexico, Arizona, Colorado, Utah) has the highest concentration. Activities: opening disused cabins, cleaning barns or sheds, farming, hiking, and camping in endemic areas
  • United Kingdom and Europe: HFRS from Puumala virus (bank vole) and Seoul virus (brown rat) occurs across Northern and Central Europe. Finland, Sweden, Russia, and Germany report thousands of cases annually. UK cases have been linked to activities near waterways, farms, and woodland
  • High-risk occupations: farmers, construction workers, forestry workers, pest control operatives, military personnel in field conditions, plumbers working under buildings, anyone cleaning long-disused properties
  • High-risk activities: camping in rodent-endemic areas, hiking in grasslands or forests, cleaning garages, attics, basements, or outbuildings that may harbour rodents
  • Seasonal pattern: cases peak in spring and early summer in the US (after winter rodent population expansion indoors) and late summer to autumn in Europe

You do not need to be bitten by a rodent to get Hantavirus. Simply breathing in dust from a space where infected rodents have been living — a garage, attic, barn, or disused building — is sufficient for transmission.

How Is Hantavirus Diagnosed? The Complete Blood Test Guide

Hantavirus diagnosis requires a combination of clinical suspicion (exposure history + symptoms) and specific laboratory testing. No single test is definitive in isolation — doctors use a panel of blood and urine tests together to build the clinical picture. Here is what each test measures and what abnormal results mean in Hantavirus:

Complete Blood Count (CBC) in Hantavirus — What to Look For

The CBC is the first and most informative blood test in suspected Hantavirus infection. It shows characteristic abnormalities that, when combined with the right exposure history, should prompt immediate Hantavirus testing. The CBC pattern in Hantavirus is distinctive and differs from typical bacterial or common viral infections.

  • Thrombocytopenia (low platelets): platelet count drops — often below 150,000/µL and sometimes critically low (below 50,000/µL). This is one of the most consistent early findings in both HPS and HFRS
  • Leukocytosis with left shift: elevated white blood cell count with increased immature neutrophils (band cells) — indicating severe systemic infection. WBC may exceed 20,000/µL in severe cases
  • Immunoblasts in peripheral smear: large, activated lymphocytes visible on blood film — this finding is highly characteristic of Hantavirus and is used by experienced haematologists as an early clue
  • Elevated haematocrit (haemoconcentration): in HPS, plasma leaks from blood vessels into lung tissue — causing the blood to become more concentrated. A rising haematocrit in a febrile patient with low platelets is a red flag
  • Anaemia: in HFRS, haemorrhagic complications cause falling haemoglobin
  • Elevated LDH (lactate dehydrogenase): marker of tissue damage — significantly elevated in HPS, correlates with disease severity

The classic CBC triad in Hantavirus: low platelets + elevated WBC + rising haematocrit. This combination in a patient with rural or rodent exposure and fever warrants immediate isolation and Hantavirus serology.

Kidney Function Tests in HFRS — Creatinine, BUN, and eGFR

In Hemorrhagic Fever with Renal Syndrome (HFRS) — the European and Asian form of Hantavirus disease — the kidneys are the primary target organ. Kidney function tests are essential for monitoring disease severity, guiding fluid management, and determining the need for dialysis.

  • Serum creatinine: rises rapidly as kidney tubules are damaged — levels above 200 µmol/L (2.3 mg/dL) indicate significant kidney injury; levels above 500 µmol/L (5.7 mg/dL) indicate severe acute kidney injury requiring specialist input
  • Blood Urea Nitrogen (BUN): elevated alongside creatinine — BUN:creatinine ratio helps distinguish pre-renal dehydration from intrinsic renal injury
  • eGFR (estimated glomerular filtration rate): calculated from creatinine — drops precipitously in HFRS. An eGFR below 30 mL/min/1.73m² indicates stage 4 kidney disease severity and requires urgent nephrology review
  • Electrolytes: sodium and potassium become critically dysregulated — hyperkalaemia (high potassium above 6.0 mEq/L) is life-threatening and a dialysis trigger
  • Phosphate: elevated due to reduced kidney excretion
  • Urine protein (proteinuria): one of the earliest signs of HFRS — large amounts of protein in urine indicate glomerular damage. A urine dipstick showing 3+ or 4+ protein in a febrile patient warrants urgent investigation

In HFRS, the kidneys typically recover — but the acute phase can be severe enough to require temporary dialysis. Most patients with Puumala virus (European strain) experience milder kidney injury than those infected with Hantaan virus (Asian strain), with most recovering fully within weeks to months.

Liver Function Tests (LFTs) in Hantavirus

The liver is frequently involved in Hantavirus infection, though it is rarely the primary organ failure. LFT abnormalities are common and clinically useful for monitoring disease severity.

  • ALT (alanine aminotransferase): mildly to moderately elevated — typically 2 to 5 times the upper limit of normal
  • AST (aspartate aminotransferase): similarly elevated — an AST:ALT ratio above 2 may suggest hepatic involvement
  • Bilirubin: may be mildly elevated — significant hyperbilirubinaemia (jaundice) is uncommon but can occur in severe cases
  • Albumin: low albumin (hypoalbuminaemia) in HPS reflects capillary leak — plasma protein is lost as fluid escapes blood vessels into lung tissue
  • Prothrombin time (PT/INR): may be prolonged — indicates coagulopathy risk, which together with low platelets creates dangerous bleeding potential

Specific Hantavirus Serology and PCR Tests

The definitive diagnosis of Hantavirus requires specific serological or molecular testing, which must be requested explicitly — unlike CBC and metabolic panels, these tests are not part of routine blood work and must be ordered based on clinical suspicion.

  • Hantavirus IgM ELISA: detects acute infection — IgM antibodies appear within the first few days of symptom onset and remain detectable for 1 to 3 months. A positive IgM in the context of compatible symptoms and exposure history is diagnostic
  • Hantavirus IgG ELISA: appears slightly later and persists for years — IgG alone indicates past exposure, not necessarily current infection
  • IgM + IgG both positive: consistent with acute infection or recent reinfection
  • RT-PCR (reverse transcriptase polymerase chain reaction): detects Hantavirus RNA directly in blood — most sensitive in the first few days of illness before the immune response is established. The test of choice for early diagnosis but requires specialised laboratory facilities
  • Immunohistochemistry: used on tissue samples (biopsy or post-mortem) — detects Hantavirus antigens in cells. Used in fatal cases to confirm diagnosis
  • In the UK: PHE (Public Health England/UKHSA) reference laboratory performs confirmatory testing. In the US: CDC Hantavirus Laboratory or state public health labs

If Hantavirus is suspected clinically — rodent exposure + fever + low platelets + respiratory or kidney symptoms — do not wait for confirmatory serology before beginning supportive treatment. Notify your local public health authority and transfer to intensive care if HPS is suspected.

Hantavirus Treatment — What Medicine Can and Cannot Do

There is currently no FDA-approved specific antiviral treatment for Hantavirus infection. Treatment is primarily supportive — meaning doctors manage the symptoms and complications while the immune system fights the virus. The quality and speed of supportive care is the primary determinant of survival.

  • HPS treatment: intensive care unit admission, mechanical ventilation for respiratory failure, extracorporeal membrane oxygenation (ECMO) for the most severe cases — ECMO has significantly improved survival rates in specialist centres
  • HFRS treatment: careful fluid management (too little causes kidney failure, too much causes pulmonary oedema), dialysis for severe acute kidney injury, blood pressure support with vasopressors
  • Ribavirin: an antiviral drug shown to reduce mortality in HFRS (Hantaan and Seoul virus) when given early — particularly effective in the first 4 days of illness. It has NOT been proven effective for HPS (Sin Nombre virus) in clinical trials
  • Do NOT use NSAIDs (ibuprofen, naproxen, aspirin): these drugs inhibit platelet function and increase bleeding risk — dangerous in Hantavirus where platelets are already critically low
  • Paracetamol/acetaminophen is safe for fever management
  • No Hantavirus vaccine is currently approved for use in the United States, United Kingdom, or European Union

The single most important factor in HPS survival is early transfer to a hospital with ECMO capability. If a patient deteriorates rapidly with pulmonary oedema, arrange immediate transfer before respiratory failure becomes irreversible.

Hantavirus Prevention — Practical Steps for the US, UK, and Europe

Since there is no approved vaccine and no specific treatment for HPS, prevention is the only reliable protection. These CDC and NHS-endorsed measures significantly reduce your risk of exposure:

  • Seal rodent entry points: close all gaps larger than 6mm in walls, floors, and roofs using steel wool and caulk — mice can squeeze through very small openings
  • Before entering disused buildings: air out the space for 30 minutes before entering; do not sweep or vacuum rodent droppings (this aerosolises the virus)
  • Cleaning contaminated areas: wet the area with a bleach solution (1 part bleach to 10 parts water) first — this kills the virus before it can become airborne
  • Use PPE: when cleaning spaces with rodent evidence, wear a well-fitted N95 respirator mask (not a surgical mask), rubber or plastic gloves, and eye protection
  • Camping and hiking: do not sleep directly on the ground in endemic areas; keep food in sealed containers; do not disturb rodent burrows or nests
  • Control rodent populations: set traps around the home, remove food sources (bird seed, open compost, pet food), keep wood piles away from the house
  • After handling rodents or contaminated materials: wash hands thoroughly with soap and water for at least 20 seconds

The bleach-before-you-clean rule is the most important prevention step that most people skip. Dry sweeping or vacuuming rodent droppings without wetting them first sends virus particles directly into the air you breathe. Always wet first, then wipe — never sweep dry.

Understand Your Blood Test Results with LabSense AI

If you have had blood tests and are concerned about abnormal results — low platelets, elevated creatinine, abnormal WBC, raised liver enzymes — LabSense AI can help you understand what each value means in plain English. Enter your CBC, metabolic panel, or kidney function test results and get an instant, clinically grounded explanation. Free, no sign-up, trusted in the US, UK, and 50+ countries.

LabSense AI is an educational tool. If you suspect Hantavirus exposure or have symptoms alongside abnormal blood tests, seek emergency medical care immediately. Do not rely on any AI tool to replace clinical evaluation for a potentially life-threatening infection.

Frequently Asked Questions

What are the first signs of Hantavirus infection?

The early symptoms of Hantavirus are non-specific and easily mistaken for influenza: sudden high fever (38–40°C), severe muscle aches — especially in the thighs, hips, and back — headache, chills, and profound fatigue. Nausea, vomiting, and abdominal pain may also occur. These prodromal symptoms last 3 to 5 days before the disease-specific phase begins. In HPS, shortness of breath follows. In HFRS, back pain and reduced urination develop. The key distinguishing feature is rodent exposure in the 1 to 5 weeks before symptoms.

What does Hantavirus do to your blood test results?

Hantavirus produces a characteristic set of blood test abnormalities: low platelet count (thrombocytopenia), elevated white blood cell count with immature cells (left shift), rising haematocrit (blood concentration from capillary leak in HPS), elevated LDH, and the presence of immunoblasts on peripheral blood smear. In HFRS specifically, creatinine and BUN rise as the kidneys fail, electrolytes become dysregulated, and urinalysis shows protein and blood in the urine. The CBC triad of low platelets + high WBC + rising haematocrit in a patient with rodent exposure is the classic early warning pattern.

How is Hantavirus diagnosed — what specific tests are used?

Hantavirus is confirmed by specific serology (IgM and IgG ELISA) or RT-PCR. IgM antibodies appear within days of symptom onset and confirm acute infection. RT-PCR detects viral RNA directly and is most sensitive in the early days before the antibody response develops. In the United States, confirmatory testing is performed by the CDC and state public health laboratories. In the UK, the UK Health Security Agency (UKHSA) reference laboratory handles confirmatory testing. Routine blood tests (CBC, metabolic panel) support the diagnosis but cannot confirm it without specific Hantavirus testing.

Is Hantavirus contagious — can it spread person to person?

Almost all Hantavirus strains do not spread person to person. The global rule is: Hantavirus is transmitted only from infected rodents to humans, through inhalation of contaminated dust, direct contact with rodent materials, or rarely rodent bites. The critical exception is the Andes virus in South America (Argentina and Chile), which has documented cases of human-to-human transmission. All other strains — including Sin Nombre virus (USA), Puumala virus (Europe), Hantaan virus (Asia), and Seoul virus (worldwide) — do not spread between people.

What is the survival rate for Hantavirus?

Survival rates differ significantly between the two main disease forms. Hantavirus Pulmonary Syndrome (HPS, Americas) has a case fatality rate of approximately 30 to 40% — one of the highest mortality rates of any viral disease in the United States. The fatality rate drops significantly with early ICU admission and ECMO support. Hemorrhagic Fever with Renal Syndrome (HFRS, Europe and Asia) has a lower fatality rate: Hantaan virus (Asia) causes 5 to 15% mortality, Puumala virus (Europe) causes less than 0.1% mortality. Seoul virus globally causes approximately 1% mortality. Early hospitalisation and supportive care are the most important determinants of survival.

Is there a vaccine for Hantavirus?

As of 2026, there is no FDA-approved, EMA-approved, or MHRA-approved vaccine for Hantavirus available in the United States, European Union, or United Kingdom. Several Hantavirus vaccines have been developed and are in use in China and South Korea (against Hantaan and Seoul viruses), but these are not approved or available in Western markets. Prevention through rodent control and avoiding exposure to contaminated rodent materials remains the only reliable protection available to people in the US and Europe.

Can you catch Hantavirus from a dead mouse?

Yes. The Hantavirus can remain infectious in dried rodent droppings, urine, and nesting materials for several days — and potentially longer in cool, humid conditions. A dead mouse itself is not the primary risk, but the contaminated materials in areas where it lived are. Handling a dead rodent with bare hands, or disturbing its nesting area without PPE, can result in exposure. Always use gloves and an N95 respirator when handling dead rodents or cleaning areas with evidence of rodent activity. Wet the area with bleach solution before any cleaning.

How is Hantavirus different from dengue fever in blood tests?

Both Hantavirus and dengue fever cause low platelet counts (thrombocytopenia) and are transmitted by different vectors (rodents for Hantavirus, mosquitoes for dengue). Key differences in blood tests: dengue shows a more pronounced platelet drop with relatively normal creatinine; Hantavirus HFRS shows dramatic kidney failure (rising creatinine, falling eGFR) alongside low platelets. HPS causes haemoconcentration (rising haematocrit) and pulmonary involvement not seen in dengue. Serology tests are completely different — dengue NS1, IgM, IgG are distinct from Hantavirus ELISA tests. Geographic exposure and season help distinguish them clinically.

#hantavirus 2026#hantavirus symptoms#hantavirus blood test#hantavirus diagnosis#hantavirus pulmonary syndrome#hantavirus hemorrhagic fever renal syndrome#HFRS blood test#HPS symptoms 2026#hantavirus CBC results#how is hantavirus diagnosed#hantavirus from mice#sin nombre virus symptoms#puumala virus Europe#hantavirus treatment#hantavirus prevention#hantavirus platelet count#rodent borne virus symptoms#hantavirus outbreak 2026#hantavirus kidney disease#hantavirus creatinine elevated#hantavirus mortality rate#hantavirus United States#hantavirus Europe UK#hantavirus early warning signs#hantavirus blood work explained

Medical Advisory

Expert oversight & content review

Dr. Naeem Mahmood Ashraf
✓ Verified

Dr. Naeem Mahmood Ashraf

PhD Biochemistry & Biotechnology

University of Punjab, Lahore

Dr. Naeem Mahmood Ashraf is a distinguished biochemist and biotechnologist at the University of Punjab, Lahore, Pakistan. With a PhD in Biochemistry & Biotechnology and over 45 peer-reviewed publications (h-index: 10), Dr. Ashraf brings deep expertise in clinical biochemistry, genomics, and computational biology to LabSense AI. His research bridges laboratory science and patient care, ensuring all interpretations follow WHO, IFCC, and AACC international standards.

45+
Publications
10
h-index
20+
Years Exp.

Credentials

PhD Biochemistry & Biotechnology
45+ Peer-Reviewed Publications
h-index: 10
Computational Biology Expert
Clinical Biochemistry Specialist

Areas of Expertise

Clinical Biochemistry
Genomics & Proteomics
Computational Biology
Lab Diagnostics
Medical Biotechnology